In conclusion, this study showed that zaltoprofen activated PPARγ and subsequently decreased MMP2 activity in human chondrosarcoma cells, thereby contributing to anti‐tumor effects against cell viability, proliferation, migration, and invasion. This evidence concerns the gene PPARG and chondrosarcoma.